Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

331.P1.42 Pathophysiology of Thrombosis Poster I

Saturday, December 6, 2008: 5:30 PM-7:30 PM
Hall A (Moscone Center)
Free Protein S Levels on the Risk of First Venous Thrombosis and Recurrence. Results from a Retrospective Family Cohort Study in 1143 Relatives

Willem M Lijfering, MD*, René Mulder*, Min Ki ten Kate*, Andre Mulder* and Jan van der Meer*

University Medical Center Groningen, Groningen, Netherlands

Association of Elevated Soluble P-Selectin Levels and Fetal Loss in Women with a History of Venous ThromboembolismClinically Relevant Abstract

Cihan Ay1*, Alexandra Kaider2*, Silvia Koder3*, Peter Husslein, MD4* and Ingrid Pabinger5

1Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
2Core Unit for Medical Statistics and Informatics, Medical University of Vienna, Vienna, Austria
3Division of Haematology and Haemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
4Department of Obstetrics and Gynecolocy, Medical University of Vienna, Vienna, Austria
5Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria

Levels of Inflammatory Markers and the Development of the Post Thrombotic SyndromeClinically Relevant Abstract

Hadia Shbaklo, PhD1*, Christina A Holcroft, ScD1* and Susan R Kahn, MD, MSc2

1Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, QC, Canada
2Division of Internal Medicine, Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada

VIDAS D-Dimer in Combination with Clinical Pre-Test Probability to Rule out Pulmonary Embolism. A Systematic Review of the Management Outcome StudiesClinically Relevant Abstract

Marc Carrier, MD1, Marc Righini, MD2*, Reza Karami Djurabi3*, Menno Huisman3*, Arnaud Perrier, MD4*, Philip Wells, MD, FRCPC, MSc5, Walter Wuillemin6* and Gregoire Le Gal, MD, PhD7*

1University of Ottawa, Ottawa, ON, Canada
2Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland
3Leiden University, Leiden, Netherlands
4Geneva University Hospital, Geneva, Switzerland
5Ottawa Hospital Civic Site, Ottawa, ON, Canada
6Haematology and Central Haematology Laboratory Kantonsspital, Lucerne, Switzerland
7Medicine, Ottawa Health Research Institute, Ottawa, ON, Canada

Microparticle-Associated Tissue Factor Activity and Venous Thrombosis in Multiple MyelomaClinically Relevant Abstract

Frank Leebeek, MD, PhD1, Yuana Yuana2*, Suzanne Osanto2*, Moniek de Maat1*, Hajo Auwerda1*, Rogier Bertina3* and Pieter Sonneveld, MD, PhD1

1Hematology, Erasmus Medical Center, Rotterdam, Netherlands
2Oncology, LUMC, Leiden, Netherlands
3Hematology, LUMC, Leiden, Netherlands

Decreased beta2-Glycoprotein I Plasma Levels as a Risk Factor for Myocardial Infarction in Men

Bas De Laat, PhD1, Philip G. de Groot, PhD2*, Ronald H.W.M. Derksen, MD., PhD3*, Rolf T. Urbanus4*, Koen Mertens, PhD1, Frits Rosendaal, MD, PhD5 and Carine J.M. Doggen, PhD5*

1Department of Plasma Proteins, Sanquin Blood Supply Foundation, Amsterdam, Netherlands
2Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, Netherlands
3Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands
4Department of Clinical Chemistry and Haematology, University Medical Center, Utrecht, Utrecht, Netherlands
5Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands

Risk Factors for Central Venous Line-Related Deep Vein Thrombosis and Occlusions in the Israeli Pediatric Oncology Registry

Shoshana Revel-Vilk, MD1, Joanne Yacobovich, MD2*, Hannah Tamary, MD2, Gal Goldstein, MD3*, Isaac Yaniv, MD2, Amos Toren, MD, PhD3, Polina Stephanski, MD1*, Michael Weintraub, MD1* and Gili Kenet, MD4

1Pediatric Hematology/Oncology Department, Hadassah Hebrew-University Hospital, Jerusalem, Israel
2Pediatric Hematology/Oncology Department, Schneider Children's Medical Center, Petah Tikva, Israel
3Pediatric Hematology/Oncology Department, The Chaim Sheba Medical Center, Tel Hashomer, Israel
4Thrombosis Unit, The Chaim Sheba Medical Centre, Tel Hashomer, Israel

High Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels May Protect against Recurrent Fetal LossClinically Relevant Abstract

Hendrika M Knol1*, Nic J.G.M. Veeger1*, Saskia Middeldorp2*, Karly Hamulyàk3*, Martin H Prins4*, Harry R Büller2* and Jan van der Meer1*

1Division of Haemostasis, Thrombosis and Rheology, University Medical Center Groningen, Groningen, Netherlands
2Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands
3Hematology, University Hospital Maastricht, Maastricht, Netherlands
4Clinical epidemiology and medical technology assessment, University Hospital Maastricht, Maastricht, Netherlands

Incidence of Thrombosis in Serotonin Release Assay Negative Patients and Correlation with Pretest Heparin-Induced Thrombocytopenia Scoring SystemClinically Relevant Abstract

Christopher Hueser, DO, MS1*, Anjali J Patel, DO2* and John N Allan, BS3*

1Hematology and Oncology, St. Louis University, Saint Louis, MO
2Anesthesiology and Critical Care, St. Louis University, St. Louis, MO
3St. Louis University Medical School, St. Louis, MO

Factor V Leiden Is Associated with Premature Myocardial InfarctionClinically Relevant Abstract

Flora Peyvandi1*, Marta Spreafico1*, Luisa Foco2*, Luisa Bernardinelli3*, Stefano Duga4*, Rosanna Asselta4*, Diego Ardissino5*, Sekar Kathiresan6*, Pierangelica Merlini7* and Pier M. Mannucci, MD8

1Department of Medicine and Medical Specialties, University of Milan, IRCCS Maggiore Hospital, Milan, Milan, Italy
2Dipartimento di Scienze Sanitarie Applicate e Psicocomportamentali, Università di Pavia, Pavia, Italy
3MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Cambridge, United Kingdom
4Department of Biology and Genetics for Medical Sciences, University of Milan, Milan, Italy
5Division of Cardiology, Maggiore Hospital, University of Parma, Parma, Italy
6Cardiology Division, Massachusetts General Hospital, Boston, MA
7Division of Cardiology, Azienda Ospedaliera Niguarda Ca' Granda, Milan, Italy
8Department of Medicine and Medical Specialties, University of Milan , IRCCS Maggiore Hospital, Milano, Italy

Predicting Thrombosis in Factor VLeiden Heterozygotes

Stephen J. Everse, Ph.D.1*, Thomas Orfeo, Ph.D.2*, Kathleen E. Brummel-Ziedins, Ph.D.2*, Matthew F. Hockin, Ph.D.3* and Kenneth G. Mann, Ph.D.2

1Biochemistry, University of Vermont, Burlington, VT
2Biochemistry, University of Vermont, Colchester, VT
3Human Genetics Operations, University of Utah, Salt Lake City, UT

The Association Between Antiphospholipid Antibodies and Adverse Pregnancy Outcomes: A Metaanalysis

Karim Abou-Nassar, MD1*, Marc Carrier, MD2 and Marc Rodger, MD, FRCPC3

1Hematology, University of Ottawa, The Ottawa Hospital, Ottawa, ON, Canada
2University of Ottawa, Ottawa, ON, Canada
3General Campus, Ottawa Hospital, Ottawa, ON, Canada

TF Independent Potentiation of FVIIa Activity in CAD Plasma: An Assessment Using Two Chromogenic AssaysClinically Relevant Abstract

Vladimir Bogdanov, PhD1, Giovanni Cimmino, MD2*, Jonathan G Tardos, MD1*, Brian G Choi, MD2*, Annapoorna Kini, MD2*, Samin K Sharma, MD2*, Sharad Kothari, MBBS2*, James R Tunstead, PhD2*, Sajiv Chandradas, BS1*, Bjarne Østerud, PhD3* and Juan J Badimon, PhD2*

1Mount Sinai School of Medicine, New York, NY
2The Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY
3Biochemistry, Institute of Medical Biology, University of Tromsø, Tromsø, Norway

The Relationship Between D-Dimer Level, Venous Valvular Reflux and Development of the Post-Thrombotic Syndrome after Deep Venous ThrombosisClinically Relevant Abstract

Jennifer Latella, MD1*, Sylvie Desmarais, MD2*, Susan Kahn, MD3 and Veto Investigators4*

1Medicine, McGill University, Montreal, QC, Canada
2Medicine, Hopital Pierre Boucher, Montreal, QC, Canada
3Center for Clinical Epidemiology and Community Studies, Montreal, QC, Canada
4Quebec and Ontario

ADAMTS13 is a Risk Factor for MI, Stroke and Vascular Death in the Oxford Vascular Study

Jennifer Eglinton1*, Paul Harrison2*, Helen Segal3*, Louise Silver3*, Ziyah Mehta3* and Peter Rothwell3*

1Department of Haematology, Oxford Radcliffe NHS Trust, Oxford, United Kingdom
2Oxford Haemophilia & Thrombosis Centre, Churchill Hospital, Oxford, United Kingdom
3Stroke Prevention Research Unit, Department of Clinical Neurology, University of Oxford, Oxford, United Kingdom

Adamts-13 Gene Mutations and Transcription Analysis in Primary Antiphospholipid Syndrome

Veysel sabri Hancer1*, Reyhan Diz-Kucukkaya2* and Aysegul topal-Sarikaya3*

1Hematology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
2Hematology, Istanbul Faculty of Medicine, Istanbul University, Gokturk, Istanbul, Turkey
3Molecular Biology and Genetics, Faculty of Science, Istanbul University, Istanbul, Turkey

Circulating Blasts Are Associated with High Levels of vWF and Thrombin Activation in Children with Newly Diagnosed ALL

Uma Athale, MD1, Albert Moghrabi, MD2, Trishna Nayiager, BScH3*, Delva Yves-Line4*, Lehana Thabane, Ph.D.5* and Anthony Chan, MBBS6

1Div. of Pediatric Hematology/Oncology, McMaster University, Hamilton, ON, Canada
2Room A-490, St. Justine Hospital, Montreal, QC, Canada
3Pediatrics, McMaster Children's Hospital, Hamilton, Canada
4Clinical Research Hematology/Oncology, Hospital Ste. Justine, Montreal, Canada
5Ce & B, McMaster University, Hamilton, Canada
6McMaster University, Hamilton, ON, Canada

In Vivo Neutralization of Unfractionated Heparin and Low Molecular Weight Heparin by a Novel Salicylamide Derivative

Jacqueline Kuziej1*, Evangelos Litinas2*, Debra Hoppensteadt2*, Dahui Liu, Ph.D.3*, Jeanine M. Walenga, PhD4, Jawed Fareed, PhD5 and Walter Jeske6*

1Loyola University Medical Center, Maywood, IL
2Pathology, Loyola University Medical Center, Maywood, IL
3PolyMedix, Inc., Radnor, PA
4Cardiovascular Institute, Loyola Univ. Medical Center, Maywood, IL
5Loyola Univ. Medical Ctr., Maywood, IL
6Cardiovascular Institute, Loyola University Medical Center, Maywood, IL

Thrombin Generation Is Normal in Most Patients with Cirrhosis despite a Prolonged INR

Alexander Gatt, MD, MRCP, FRCPath1*, Anne Riddell1*, Vincenza Calvaruso2*, Michael Makris, MD3, Edward Tuddenham4* and Andrew Burroughs2*

1Hemophilia Ctr. & Thrombosis Unit, The Royalfree Hospital, London, United Kingdom
2Royal Free Hospital, London,UK, Hepatology and Liver Transplantation Unit, London, United Kingdom
3Dept. of Haematology, Sheffield Teaching Hospitals Trust, Sheffield, ARRAY(0xc0e07c8)
4Hemophilia Ctr. & Thrombosus Unit, The Royalfree Hospital, London, ARRAY(0xc7e9c90)

Prothrombin 20209C>T: Thirteen New Cases and Association with the 19911A>G Polymorphism

Ilka Warshawsky, MD, PhD1*, Vinit Makkar, MD2* and Kandice Kottke-Marchant, MD, PhD3

1Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH
2Hematology and Medical Oncology, Cleveland Clinic Beachwood, Beachwood, OH
3Clinical Pathology, Cleveland Clinic, Cleveland, OH

Clinical and Laboratory Risk Factors for Venous Thromboembolism in Patients with High-Grade Gliomas: Results of a Prospective Study of 107 Newly-Diagnosed Patients

Michael B. Streiff, MD1, Xiaobu Ye, MD2*, Serena Desideri, MD2*, Thomas Kickler, MD3*, Jayesh Jani3* and Stuart Grossman, MD2*

1Johns Hopkins Medical Institutions, Baltimore, MD
2Oncology, Johns Hopkins Medical Institutions, Baltimore, MD
3Pathology, Johns Hopkins Medical Institutions, Baltimore, MD

*signifies non-member of ASH